Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

Bioretec: Offering to be completed in April

Research 2026-03-30 09:04 by Antti Siltanen
Bioretec

US market roadmap for medical devices – a European perspective

Analyst Comment 2026-03-27 11:45 by Antti Siltanen
BioretecAiforia TechnologiesNightingale HealthNexstim

Nexstim received new sales clearances in the United States

Analyst Comment 2026-03-24 08:18 by Antti Siltanen
Nexstim

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Aiforia secures another CE-IVD mark

Analyst Comment 2026-03-18 07:41 by Antti Siltanen
Aiforia Technologies

Aiforia H2’25: Green shoots on the clinical side

Video 2026-03-16 10:29 by Antti Siltanen, Isa Hudd
Aiforia Technologies

Faron:

Research 2026-03-12 09:27 by Antti Siltanen
Faron Pharmaceuticals

New partnership for Aiforia

Analyst Comment 2026-03-11 07:49 by Antti Siltanen
Aiforia Technologies

Terms of Faron's rights offering have been published

Analyst Comment 2026-03-11 07:33 by Antti Siltanen
Faron Pharmaceuticals

Bioretec is planning rights issue worth 5-15 MEUR

Analyst Comment 2026-03-11 07:45 by Antti Siltanen
Bioretec

Aiforia H2'25: Green shoots on the clinical side

Research 2026-03-09 09:51 by Antti Siltanen
Aiforia Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.